Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
Curr Cancer Drug Targets. 2020;20(6):410-416. doi: 10.2174/1568009620666200414151419.
The outbreak of COVID-19 due to SARS-CoV-2 originally emerged in Wuhan in December 2019. As of March 22, 2020, the disease spread to 186 countries, with at least 305,275 confirmed cases. Although there has been a decline in the spread of the disease in China, the prevalence of COVID-19 around the world remains serious despite containment efforts undertaken by national authorities and the international community. In this article, we systematically review the brief history of COVID-19 and its epidemic and clinical characteristics, highlighting the strategies used to control and prevent the disease in China, which may help other countries respond to the outbreak. This pandemic emphasizes the need to be constantly alert to shifts in both the global dynamics and the contexts of individual countries, making sure that all are aware of which approaches are successful for the prevention, containment and treatment of new diseases, and being flexible enough to adapt the responses accordingly.
由于 SARS-CoV-2 引起的 COVID-19 疫情最初于 2019 年 12 月在武汉爆发。截至 2020 年 3 月 22 日，该疾病已传播至 186 个国家，至少有 305275 例确诊病例。尽管中国的疫情传播有所下降，但尽管各国当局和国际社会采取了遏制措施，全球 COVID-19 的流行仍然严重。在本文中，我们系统地回顾了 COVID-19 的简要历史及其流行和临床特征，强调了中国用于控制和预防该疾病的策略，这可能有助于其他国家应对疫情。这次大流行强调需要时刻警惕全球动态和个别国家背景的变化，确保所有人都了解哪些方法对预防、控制和治疗新疾病是有效的，并具有足够的灵活性来相应地调整应对措施。
